Invention Grant
- Patent Title: DNase H activity of Neisseria meningitidis Cas9
-
Application No.: US17870336Application Date: 2022-07-21
-
Publication No.: US12104183B2Publication Date: 2024-10-01
- Inventor: Erik J. Sontheimer , Yan Zhang
- Applicant: UNIVERSITY OF MASSACHUSETTS
- Applicant Address: US MA Boston
- Assignee: UNIVERSITY OF MASSACHUSETTS
- Current Assignee: UNIVERSITY OF MASSACHUSETTS
- Current Assignee Address: US MA Boston
- Agency: Medlen & Carroll, LLP
- The original application number of the division: US15758394
- Main IPC: C12N9/22
- IPC: C12N9/22 ; A61K38/00 ; C12N15/11

Abstract:
Many strains of the human pathogen Neisseria meningitidis carry a compact Cas9 (NmeCas9) that can serve to limit genetic exchange via natural transformation. Cas9 orthologues (including NmeCas9) have recently been adopted for RNA-guided genome engineering and DNA binding, adding to the need to define better their activities and properties. The present invention examines DNA cleavage activities and substrate requirements of NmeCas9, including a set of unusually complex PAM recognition patterns. Unexpectedly, NmeCas9 is found able to cleave single-stranded DNA (ssDNA) targets in a manner that is RNA-guided but both PAM- and tracrRNA-independent. Beyond the requirement for guide-target pairing, this activity has no apparent sequence requirements, and the cleavage sites are measured from the 5′ end of the DNA substrate's RNA-paired region. These results indicate that tracrRNA domains are not strictly required for enzymatic activation of NmeCas9, and expand the list of targeting activities exhibited by these revolutionary RNA-guided nucleases.
Public/Granted literature
- US20230132569A1 DNase H Activity of Neisseria Meningitidis Cas9 Public/Granted day:2023-05-04
Information query